Marinela Gombosev is CEO of Evoke Neuroscience, a data and diagnostics company focused on reducing the number of people living with treatable cognitive impairment. 60,000 patients have been assessed using Evoke’s EEG based technology and the company has twice been ranked in the Inc. 500|5000 fastest growing private companies. 40% of dementia cases can be prevented or delayed through 12 modifiable risk factors. At Evoke, we make it our mission to help physicians discover signs of cognitive impairment while there’s still time to treat. Marinela Gombosev has 15 years of leadership experience scaling operations, product development and execution of marketing strategies in regulated industries. Prior to Evoke, Marinela led product development for diagnostic devices at BIT Group, an integrated, multi-national R&D and manufacturing firm. During her tenure, Marinela built and ran a 20 person engineering team to develop a cutting edge automated robotic analyzer for allergy and auto-immune disorders, and is an inventor on two patents.